Synthimed Labs Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
- Paid Up Capital ₹ 37.80 Cr
- Company Age 1 Year 6 Months
- Open Charges ₹ 1,050.00 Cr
About Synthimed Labs
Synthimed Labs Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 July 2023 (One year and six months 10 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 37.80 Cr.
The company currently has active open charges totaling ₹1,050.00 Cr.
The Key Managerial Personnel (KMP) at Synthimed Labs Private Limited India are Abhijeet Kamasamudram as Cfo, Renu Pandey as Company Secretary, and Kacharu Toshniwal as Ceo. Mrinal Chandran, Shitij Kale, Hrishikesh Samant, and One other member serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21001CH2023PTC045205
-
Company No.
045205
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jul 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Synthimed Labs?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kacharu Toshniwal | Managing Director | 07-Jun-2024 | Current |
Abhijeet Kamasamudram | CFO | 21-Feb-2024 | Current |
Renu Pandey | Company Secretary | 17-Dec-2024 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mrinal Chandran | Nominee Director | 14-Feb-2024 | Current |
Shitij Kale | Nominee Director | 25-Jul-2023 | Current |
Hrishikesh Samant | Nominee Director | 09-Oct-2023 | Current |
Financial Performance of Synthimed Labs.
Enhance accessibility to Synthimed Labs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Synthimed Labs?
Unlock access to Synthimed Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1,050.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 1050.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
13 Mar 2024 | Others | ₹1,050.00 Cr | Open |
How Many Employees Work at Synthimed Labs?
Unlock and access historical data on people associated with Synthimed Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synthimed Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthimed Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.